November 24, 2008

A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing

Read More
Biederman J & J Risperdal Documents

November 24, 2008

The New York Times reports (below) "Dr. Biederman’s work helped to fuel a 40-fold increase from 1994

Read More
Biederman J & J Risperdal Documents

November 18, 2008

The New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic

Read More
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach